Top Midday Stories: Pfizer to Acquire Metsera for $4.9 Billion; Oracle to Secure TikTok Algorithm in Proposed Deal

MT Newswires Live
2025/09/22

All three major US stock indexes were up in late-morning trading Monday after performing strongly last week.

In company news, Pfizer (PFE) said Monday it has entered into a definitive agreement to acquire Metsera (MTSR) for $47.50 per share in cash, valuing the company at about $4.9 billion. The deal will add differentiated oral and injectable incretin, non-incretin and combination therapy candidates to its pipeline. Pfizer shares were up 2.2% around midday, while those of Metsera shares were up 62.4%.

Oracle (ORC) would provide security for an new US version of TikTok's algorithm as part of a deal to sell the Chinese-owned app to a group of American investors, Bloomberg reported Monday, citing a White House official. Separately, Oracle said Monday it promoted Clay Magouyrk and Mike Sicilia to the roles of chief executive officers. Magouyrk previously served as president of Oracle Cloud Infrastructure, while Sicilia previously served as president of Oracle Industries. The company also said it appointed former CEO Safra Catz as executive vice chair of the board of directors. Oracle shares were up 4.2%.

T-Mobile US (TMUS) said Monday it has named Chief Operating Officer Srini Gopalan as CEO, effective Nov. 1. Gopalan will replace Mike Sievert, who is taking over the newly created role of vice chairman at T-Mobile. Shares of T-Mobile were up 0.1%.

Cosan (CSAN) shares fell sharply on Monday after the Brazilian commodity conglomerate announced plans to issue up to 2 billion shares through two public offerings. Cosan shares were down 23.7%.

Price: 24.56, Change: +0.52, Percent Change: +2.18

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10